#Drug Pricing

Lead report

Eli Lilly CEO Opposes Drug Pricing Agreement Legislation: US Pharma Sector Analysis

Eli Lilly's CEO publicly opposes codifying Trump-era drug pricing agreements into law, analyzing implications for the pharmaceutical industry and US stock investments.